HOW MUCH DO I GIVE? REEVALUATION OF INSULIN DOSING ESTIMATION FORMULAS USING CONTINUOUS GLUCOSE MONITORING

被引:17
|
作者
King, Allen B. [1 ]
机构
[1] Diabet Care Ctr, Salinas, CA USA
关键词
D O I
10.4158/EP09308.OR
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To reevaluate current formulas for determining the total basal insulin dosage (TBD), insulin to carbohydrate ratio (ICR), and correction factor (CF) from weight or total daily dosage (TDD) in pump-treated patients with type 1 diabetes mellitus. Methods: From a post hoc analysis of data from 4 previously published studies, subjects who met the inclusion criteria were selected. No subject was duplicated. For all studies, the basal glucose target was to have fewer than 20% of glucose readings greater than 170 mg/dL and to have 10% or fewer glucose readings less than 70 mg/dL. Bolus insulin was adjusted to achieve a 2- to 4-hour postbolus glucose value within 20% of the premeal glucose (ICR) or 80 to 120 mg/dL from premeal hyperglycemia (CF). In the first 2 studies, dosing titration by CGM was performed from 72-hour CGM tracings every week to every 6 weeks. In the other 2 studies, 24- to 72-hour CGM downloads and insulin adjustments were done each weekday. Results: Of 101 participants, 61 (59% women) met the inclusion criteria. Estimation formulas could be rounded to the following: TBD = 0.2 x weight (kg) or 0.4 x TDD; ICR = 300 divided by TDD; and CF = 1500 divided by TDD. In particular the relationship between all 3 dosing factors could be represented as 100 divided by TBD = ICR = CF divided by 4.5. Conclusions: These results suggest that current formulas give a higher estimate for TBD and a lower estimate for the bolus dose. (Endocr Pract. 2010;16:428-432)
引用
收藏
页码:428 / 432
页数:5
相关论文
共 50 条
  • [11] How Well Do Continuous Glucose Monitoring Systems Perform During Exercise?
    Castle, Jessica R.
    Rodbard, David
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (06) : 305 - 309
  • [12] Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus
    Breton, Marc D.
    Patek, Stephen D.
    Lv, Dayu
    Schertz, Elaine
    Robic, Jessica
    Pinnata, Jennifer
    Kollar, Laura
    Barnett, Charlotte
    Wakeman, Christian
    Oliveri, Mary
    Fabris, Chiara
    Chernavvsky, Daniel
    Kovatchev, Boris P.
    Anderson, Stacey M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (08) : 531 - 540
  • [14] Remote Initiation of Continuous Glucose Monitoring in Older Adults Using Insulin
    Mahoney, Catherine
    Slyne, Christine
    Munshi, Medha
    Conery, Colin D.
    Brabant, Haley
    Krakoff, Noa
    Bulger, Jane D.
    Weinstock, Ruth S.
    Toschi, Elena
    DIABETES, 2024, 73
  • [15] Continuous glucose monitoring in persons with type 2 diabetes not using insulin
    Cowart, Kevin
    Updike, Wendy H.
    Franks, Rachel
    EXPERT REVIEW OF MEDICAL DEVICES, 2021, 18 (11) : 1049 - 1055
  • [16] Satisfaction with Continuous Glucose Monitoring: How Do the Experiences of Insulin-Using Adults with Type 1 Diabetes vs. Type 2 Diabetes Differ?
    Polonsky, William H.
    Hessler, Danielle
    Ruedy, Katrina
    Beck, Roy W.
    DIABETES, 2017, 66 : A238 - A238
  • [17] Evaluation of a novel continuous glucose monitoring guided system for adjustment of insulin dosing - PumpTune: a randomized controlled trial
    Anderson, Donald
    Phelan, Helen
    Jones, Katie
    Smart, Carmel
    Oldmeadow, Christopher
    King, Bruce
    Crock, Patricia
    PEDIATRIC DIABETES, 2016, 17 (07) : 478 - 482
  • [19] Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections
    Foster, Nicole C.
    Miller, Kellee M.
    Tamborlane, William V.
    Bergenstal, Richard M.
    Beck, Roy W.
    DIABETES CARE, 2016, 39 (06) : E81 - E82
  • [20] HOW PEOPLE USE DIRECTION AND RATE OF CHANGE INFORMATION PROVIDED BY REAL-TIME CONTINUOUS GLUCOSE MONITORING (RT-CGM) TO ADJUST INSULIN DOSING
    Pettus, J.
    Price, D. A.
    Hill, K. J.
    Edelman, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A76 - A77